Q&A: Microsoft research head explains how generative AI could help doctors be more human
Generative AI is having a moment. Peter Lee, who oversees Microsoft’s approach to health care and co-authored the 2023 book “The AI Revolution in
Generative AI is having a moment. Peter Lee, who oversees Microsoft’s approach to health care and co-authored the 2023 book “The AI Revolution in
Quest Diagnostics is building out its artificial intelligence-powered cancer pathology offerings through a multilayered deal with PathAI—acquiring some assets and licensing out others. | Quest…
Measures of biological age have exploded into health research and have fueled hype around consumer tests. But the field of aging has still not settled…
A deep-learning model reveals the rules that define transcription initiation
Chang’e-6 to target the largest and oldest lunar impact crater
When asked about the most challenging part of turning TILs into therapies, it is expanding a sample into billions of cells.
About 1.5 million adults in the U.S. are living with rheumatoid arthritis (RA), an autoimmune disease in which the immune system attacks joint tissue, causing…
In a rare observed case of self-treatment in a wild animal, scientists documented an orangutan applying a medicinal plant to a wound on his face.
Extensive testing of pasteurized commercially purchased milk and other dairy products from 38 states found no evidence of live H5N1 bird flu virus.
Novartis already produces the leading drug in the radiopharmaceutical field. Now, it is devoting even more attention to these cancer treatments with a new acquisition.
BridgeBio Pharma is spinning out its oncology subsidiary into a fully independent company, as it concentrates its resources on an anticipated launch of its pivotal…